BILL ANALYSIS
HR7277
BULLISHEmergency Medical Services Reimbursement for On-Scene and Support Act
HR7277 (Emergency Medical Services Reimbursement for On-Scene and Support Act) carries an AI-assessed market impact score of 5/10 with a bullish outlook for investors. This legislation directly affects $EVH and $LH. The primary sectors impacted are Healthcare. View the full bill text on Congress.gov.
5/10
Impact Score
bullish
Market Sentiment
2
Affected Stocks
1
Sectors Impacted
Key Takeaways for Investors
Medicare will cover on-scene ambulance services without transport, effective January 1, 2026.
This creates a new, significant revenue stream for ambulance service providers.
Ambulance companies like Acadian Healthcare ($AMED) and Envision Healthcare ($EVH) are direct beneficiaries.
How HR7277 Affects the Market
Ambulance service providers will experience a bullish impact due to expanded Medicare reimbursement. Companies such as Acadian Healthcare and Envision Healthcare ($EVH) will see increased revenue potential. LabCorp ($LH) also stands to benefit from its emergency medical services operations.
Bill Details
| Metric | Value |
|---|---|
| Bill Number | HR7277 |
| Impact Score | 5/10AI Adjustment: AI detected additional qualitative factors (+1) · Legislative Stage: Committee action |
| Market Sentiment | bullish |
| Event Date | |
| Affected Sectors | Healthcare |
| Affected Stocks | $EVH, $LH |
| Source | View on Congress.gov → |
Summary
This bill expands Medicare coverage for ambulance services to include on-scene treatment without transport, effective January 1, 2026. This creates a new revenue stream for ambulance service providers by reimbursing for services previously uncompensated. Companies operating ambulance services will see increased Medicare revenue.